Report #2844845

Received Jun 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: TX
Recovered: Unknown
Vaccinated: Aug 1, 2024
Onset: Aug 1, 2024
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	—	IM

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

Had the First Dose of HEPLISAV-B in August 2024 and Have Not Had the Second Dose Yet; Initial report received on 16-May-2025. A consumer reported that she, a female (age not reported), received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization in August 2024 but has not received the second dose. No medical history or concomitant medications were reported. In Aug-2024, the patient received dose 1 of a hepatitis B vaccine HEPLISAV-B (lot number, expiration date, NDC number, and site not reported) intramuscularly. At the time of report, the patient has not received the second dose of HEPLISAV-B yet. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.